Search for: "Watson Laboratories Inc."
Results 1 - 20
of 176
Sort by Relevance
|
Sort by Date
25 Dec 2022, 2:14 am
A witness testified that “Steinmetz disclosed the present invention to him on the evening of December 24, 1902, in his laboratory, at the time of a Christmas celebration. [read post]
1 Jun 2022, 3:18 pm
Paris Brothers Inc., of Kansas City, MO, is recalling dozens of specific cheese products because of potential Listeria monocytogenes contamination. [read post]
13 Dec 2021, 1:40 pm
Court of Appeals for the Federal Circuit, May 28, 2021, Bio-Rad Laboratories, Inc. v. [read post]
16 Jun 2020, 9:59 pm
Watson Laboratories Inc. and Galderma Laboratories, L.P. v. [read post]
19 Mar 2020, 1:33 pm
³Watson Laboratories, Inc. v. [read post]
18 Mar 2020, 9:55 pm
Watson Laboratories Inc. [read post]
16 Oct 2019, 9:59 pm
Actavis Laboratories UT, Inc. [read post]
16 Jul 2019, 9:15 pm
By Kevin E. [read post]
10 Jul 2019, 5:45 am
Mike Maschke, CEO, Sensi Enterprises, Inc.. [read post]
10 Jul 2019, 5:45 am
Congratulations to the following Fastcase 50 award recipients: Anette Aav, Director, IT Law Programme, University of Tartu Charlotte Alexander, Director, Legal Analytics Lab; Associate Professor, Georgia State University Jason Barnwell, Assistant General Counsel, Microsoft Raymond Bayley, CEO and Co-Founder, Novus Law LLC Kim Bennett, Founder, K Bennett Law Jess Birken, Founder, Birken Law Office Michael Bommarito, CEO and Co-Founder, LexPredict; Adjunct Professor of Law, Michigan… [read post]
14 Apr 2018, 11:46 am
Watson Labs., Inc. [read post]
1 Apr 2018, 8:25 pm
Watson Laboratories Inc., 875 F.3d 636, for the proposition that the marketing of a generic drug with labeling that encourages infringement can be viewed as causing infringement despite the fact that the innovator company published the results of clinical studies and promoted the patented use. [read post]
1 Apr 2018, 8:25 pm
Watson Laboratories Inc., 875 F.3d 636, for the proposition that the marketing of a generic drug with labeling that encourages infringement can be viewed as causing infringement despite the fact that the innovator company published the results of clinical studies and promoted the patented use. [read post]
7 Dec 2017, 9:34 pm
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
Court Of Appeals For Federal Circuit Denies Eli Lilly’s Appeal, Opens Door for Testosterone Generics
5 Dec 2017, 12:29 pm
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have been issued by the US Patent Office. [read post]
17 Nov 2017, 1:41 pm
Watson Laboratories, Inc., Civil Action No. 16-129-LPS-SRF (D.Del. [read post]
9 Nov 2017, 9:00 pm
Watson Laboratories, Inc. [read post]
24 Jun 2017, 1:16 pm
Stark in UCB, Inc., et al. v. [read post]
22 Feb 2017, 7:44 am
The FTC’s complaint identifies an anti-competitive reverse-payment agreement between Endo and Watson Laboratories, Inc. of Corona, CA, a company which was poised to introduce a generic version of Endo’s Lidoderm lidocaine patch into the U.S. market by the middle of 2012. [read post]
13 Feb 2017, 8:22 am
Sugar Inc. [read post]
